4Filed Aug 17, 8:00 PM ET

BridgeBio (BBIO) Apuli Maricel Withholds 4,714 Shares for Taxes

$BBIO · BridgeBio Pharma, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

BridgeBio (BBIO) Apuli Maricel Withholds 4,714 Shares for Taxes

What Happened

  • Apuli Maricel, BridgeBio's Chief Accounting Officer, had 4,714 shares of common stock withheld on 2026-08-16 to satisfy tax obligations related to the vesting of restricted stock units (RSUs). The withheld shares were valued at $79.86 each, totaling $376,460.
  • According to the footnote, 9,262 RSUs vested and 4,714 shares were withheld for taxes, implying 4,548 net shares were delivered to Ms. Maricel.

Key Details

  • Transaction date: 2026-08-16; Filing date: 2026-08-18 (filed within the typical two-business-day Form 4 window).
  • Price per share: $79.86; Withheld shares: 4,714; Value withheld: $376,460.
  • Footnote: F1 — withholding to satisfy tax obligation on 9,262 vested RSUs.
  • Shares owned after transaction: not disclosed in the provided filing excerpt.
  • Transaction code: F (tax withholding), not a sale (S) or purchase (P).

Context

  • This was a tax-withholding event tied to RSU vesting (a routine, administrative action). It is not an open-market sale or purchase and generally should not be interpreted as a directional signal about the officer's view of the stock.